» Articles » PMID: 36200037

Prostate Cancer Cells of Increasing Metastatic Potential Exhibit Diverse Contractile Forces, Cell Stiffness, and Motility in a Microenvironment Stiffness-dependent Manner

Overview
Specialty Cell Biology
Date 2022 Oct 6
PMID 36200037
Authors
Affiliations
Soon will be listed here.
Abstract

During metastasis, all cancer types must migrate through crowded multicellular environments. Simultaneously, cancers appear to change their biophysical properties. Indeed, cell softening and increased contractility are emerging as seemingly ubiquitous biomarkers of metastatic progression which may facilitate metastasis. Cell stiffness and contractility are also influenced by the microenvironment. Stiffer matrices resembling the tumor microenvironment cause metastatic cells to contract more strongly, further promoting contractile tumorigenic phenotypes. Prostate cancer (PCa), however, appears to deviate from these common cancer biophysics trends; aggressive metastatic PCa cells appear stiffer, rather than softer, to their lowly metastatic PCa counterparts. Although metastatic PCa cells have been reported to be more contractile than healthy cells, how cell contractility changes with increasing PCa metastatic potential has remained unknown. Here, we characterize the biophysical changes of PCa cells of various metastatic potential as a function of microenvironment stiffness. Using a panel of progressively increasing metastatic potential cell lines (22RV1, LNCaP, DU145, and PC3), we quantified their contractility using traction force microscopy (TFM), and measured their cortical stiffness using optical magnetic twisting cytometry (OMTC) and their motility using time-lapse microscopy. We found that PCa contractility, cell stiffness, and motility do not universally scale with metastatic potential. Rather, PCa cells of various metastatic efficiencies exhibit unique biophysical responses that are differentially influenced by substrate stiffness. Despite this biophysical diversity, this work concludes that mechanical microenvironment is a key determinant in the biophysical response of PCa with variable metastatic potentials. The mechanics-oriented focus and methodology of the study is unique and complementary to conventional biochemical and genetic strategies typically used to understand this disease, and thus may usher in new perspectives and approaches.

Citing Articles

Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets.

Liu Z, Zhang X, Ben T, Li M, Jin Y, Wang T Biomark Res. 2025; 13(1):38.

PMID: 40045379 PMC: 11884212. DOI: 10.1186/s40364-025-00745-7.


Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications.

Peng H, Chao Z, Wang Z, Hao X, Xi Z, Ma S Exp Hematol Oncol. 2025; 14(1):4.

PMID: 39799341 PMC: 11724500. DOI: 10.1186/s40164-024-00591-7.


Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel.

Gregori A, Bergonzini C, Capula M, de Mercado R, Danen E, Giovannetti E Cancers (Basel). 2024; 16(22).

PMID: 39594817 PMC: 11593083. DOI: 10.3390/cancers16223863.


Microfluidic Applications in Prostate Cancer Research.

Szewczyk K, Jiang L, Khawaja H, Miranti C, Zohar Y Micromachines (Basel). 2024; 15(10).

PMID: 39459070 PMC: 11509716. DOI: 10.3390/mi15101195.


Cellular Traction Force Holds the Potential as a Drug Testing Readout for In Vitro Cancer Metastasis.

Liew H, Liew X, Lin W, Lee Y, Ong Y, Ogawa S Cell Mol Bioeng. 2024; 17(3):203-217.

PMID: 39050509 PMC: 11263313. DOI: 10.1007/s12195-024-00811-4.


References
1.
Zhu M, Kyprianou N . Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. FASEB J. 2009; 24(3):769-77. PMC: 2830130. DOI: 10.1096/fj.09-136994. View

2.
Sottnik J, Daignault-Newton S, Zhang X, Morrissey C, Hussain M, Keller E . Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasis. Clin Exp Metastasis. 2012; 30(5):569-78. PMC: 3736758. DOI: 10.1007/s10585-012-9561-6. View

3.
Gensbittel V, Krater M, Harlepp S, Busnelli I, Guck J, Goetz J . Mechanical Adaptability of Tumor Cells in Metastasis. Dev Cell. 2020; 56(2):164-179. DOI: 10.1016/j.devcel.2020.10.011. View

4.
Sieh S, Taubenberger A, Rizzi S, Sadowski M, Lehman M, Rockstroh A . Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment. PLoS One. 2012; 7(9):e40217. PMC: 3434144. DOI: 10.1371/journal.pone.0040217. View

5.
Sun Y, Wang B, Leong K, Yue P, Li L, Jhunjhunwala S . Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res. 2011; 72(2):527-36. DOI: 10.1158/0008-5472.CAN-11-3004. View